Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Medical ImagingNuclear Medical

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1328864

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1328864

Radiopharmaceuticals

PUBLISHED:
PAGES: 693 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5450
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 16350

Add to Cart

Description

Table of Contents

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Radiopharmaceuticals Market to Reach $12.6 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Radiopharmaceuticals estimated at US$6.3 Billion in the year 2022, is projected to reach a revised size of US$12.6 Billion by 2030, growing at a CAGR of 9.1% over the analysis period 2022-2030. SPECT Radioisotopes, one of the segments analyzed in the report, is projected to record a 8.3% CAGR and reach US$5.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Pet Radioisotopes segment is readjusted to a revised 10% CAGR for the next 8-year period.

The U.S. Market is Estimated at $3 Billion, While China is Forecast to Grow at 11.5% CAGR

The Radiopharmaceuticals market in the U.S. is estimated at US$3 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$836.1 Million by the year 2030 trailing a CAGR of 11.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.9% and 6.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 7.9% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$757.3 Million by the year 2030.

Select Competitors (Total 137 Featured) -

  • Cardinal Health, Inc.
  • Alseres Pharmaceuticals, Inc.
  • Actinium Pharmaceuticals, Inc.
  • Advanced Accelerator Applications SA
  • Acom Srl
  • Alliance Medical Limited
  • Andarix Pharmaceuticals
  • Best Medical International, Inc.
  • Blue Earth Diagnostics Ltd.
  • Alpha Tau Medical Ltd.
  • ABX advanced biochemical compounds GmbH
  • Avid Bioservices, Inc.
  • Advanced Cyclotron Systems, Inc.
  • Bio-Nucleonics
  • Best ABT Molecular Imaging, Inc.
Show more
Product Code: MCP-1889

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Impact of COVID-19 and a Looming Global Recession
    • 2020: A Year of Disruption & Transformation
    • As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021?
    • World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
    • Pandemic-Led Disruptions Affect Radiopharmaceuticals Supply, Hindering Nuclear Medicine Procedures in Several Countries
    • Imaging Screening Volume % Change 1H 2019 Vs 1H 2020 in US Hospitals
    • Distribution Bottlenecks amid COVID-19 Crisis Leave Hospitals Struggling with Supply of Medical Radioisotopes
    • Nuclear Medicine Services Limp Back to Normalcy after Easing of COVID-19 Restrictions
    • COVID-19 Presents Generational Opportunity
    • Radiopharmaceuticals - Global Key Competitors Percentage Market Share in 2022 (E)
    • Radiopharmaceuticals Competitor Market Share Scenario Worldwide (in %): 2020E
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • An Introduction to Radiopharmaceuticals
    • Mechanism of Action
    • Global Market Prospects & Outlook
    • Key Market Drivers
    • Market Restraints
    • Recognition of Intrinsic Cost Benefits: Critical to Market Acceptance
    • Classification of Radiopharmaceuticals
    • Diagnostic Radiopharmaceuticals: The Dominant Segment
    • Key Drivers
    • Positron Emission Tomography (PET)
    • Single Photon Emission Computed Tomography (SPECT)
    • Therapeutic Radiopharmaceuticals
    • Global Supply Shortages Continue to Challenge Market Growth
    • A Glimpse at Mo-99 Processors Worldwide
    • Nuclear Research Reactor Irradiators Worldwide: A Snapshot
    • Competitive Landscape
    • Radiopharmaceuticals Competitor Market Share Scenario Worldwide (in %): 2020
    • World Brands
    • Recent Industry Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Emergence of Radiotheranostics: Dual-Functioning Radiopharmaceuticals
    • Common Radionuclides Used in Theranostic Applications
    • Radiopharmaceuticals Become Promising for Cancer Theranostics
    • Changing Role of Radiopharmaceuticals in Diagnostic and Therapeutic Applications
    • Advent of New Radiopharmaceuticals Widen Scope
    • Select New Products
    • Startups Develop Unique Radiopharmaceutical Solutions
    • Potential Role of Carbon Dots in Imaging and Theranostics
    • Nano Radiopharmaceuticals: Promising Role in Therapeutic and Imaging Applications
    • Researchers Develop New Nanoparticles to Improve Radiopharmaceutical Efficiency
    • Oncoinvent and NPL Develops Unique Method to Measure & Deliver Dosages in Radiotherapy
    • Industry Focus Gears up for Innovative Radiopharmaceuticals with Therapeutic Benefits
    • Select Commercially Available Therapeutic Radiopharmaceuticals
    • Role of Radiopharmaceuticals as Diagnostic Technology
    • PET Eclipses SPECT in Cardiovascular Imaging
    • Worldwide Installed Base of Nuclear Imaging Equipment by Modality, PET Vs SPECT: 2020
    • Cardiac Amyloidosis Visualization: A Potential Application for PET
    • Innovative Radiopharmaceuticals to Boost Cardiac Applications
    • Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    • Radiopharmaceuticals: Direct and Targeted Approach for Cancer Treatment
    • Rising Cancer Incidence Worldwide Spurs Demand
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2020
    • Number of New Cancer Cases and Deaths (in Million) by Region for 2020
    • Intra-operative Lymphatic Mapping (ILM): Creates New Opportunities for Radiopharmaceuticals in Cancer Detection
    • Growing Prominence of Therapeutic Radiopharmaceuticals for Cancer Care
    • Rise in Incidence of Neurological Disorders to Drive Growth
    • Application of PET in Drug Development to Expand Opportunities
    • Personalized Medicine Drives Nuclear Medicine
    • Drug Ineffectiveness for Select Therapeutic Categories as a Percentage of Patient Population
    • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019 and 2024
    • Gallium-68-labeled Radiopharmaceuticals: Production & Administering Challenges
    • Radiopharmaceuticals for COVID-19: Role in Diagnosis, Prognosis, and Therapeutic Uses
    • Artificial Intelligence: A Promising Tool in Radiotherapy and Radiopharmaceuticals
    • Aging Global Population: A Vital Demography
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    • Global Cancer Deaths by Age Group (in %) for 2019
    • Rise in Healthcare Expenditure to Drive Growth
    • World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021 & 2023
    • Elderly Healthcare Expenditure as a % of GDP in the US, Europe and Japan for 1970, 2010 and 2050
    • Relevant Aspects of Radiopharmaceutical Production
    • Regulatory Regime Governing Production and Use of Radiopharmaceuticals
    • The Facilitating Innovative Nuclear Diagnostics (FIND) Act, 2021
    • Challenges Facing Nuclear Medicine Industry
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Radiopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Radiopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 3: World 14-Year Perspective for Radiopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2016, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for SPECT Radioisotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for SPECT Radioisotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 6: World 14-Year Perspective for SPECT Radioisotopes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for PET Radioisotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for PET Radioisotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 9: World 14-Year Perspective for PET Radioisotopes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Beta Emitters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Beta Emitters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 12: World 14-Year Perspective for Beta Emitters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Alpha Emitters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Alpha Emitters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 15: World 14-Year Perspective for Alpha Emitters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 18: World 14-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 21: World 14-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 24: World 14-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 27: World 14-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 30: World 14-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2023 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 33: World 14-Year Perspective for Hospitals & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2023 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 36: World 14-Year Perspective for Ambulatory Surgical Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2023 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 39: World 14-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2023 & 2030
    • TABLE 40: World Radiopharmaceuticals Market Analysis of Annual Sales in US$ Thousand for Years 2016 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Market Facts & Figures
    • US Radiopharmaceuticals Market Share (in %) by Company: 2020 & 2027
    • SPECT Radioisotopes (Product Type) Market Share Analysis (in %) of Leading Players in the US for 2020 & 2027
    • PET Radioisotopes (Product Type) Competitor Revenue Share (in %) in the US: 2020 & 2027
    • Beta Emitters (Product Type) Market Share Breakdown (in %) of Major Players in the US: 2020 & 2027
    • Alpha Emitters (Product Type) Market in the US: Percentage Breakdown of Revenues by Company for 2020 & 2027
    • Radiopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • Market Overview
    • Diagnostic Applications Stimulate Future Growth
    • Demographic Changes Offer Growth Opportunities
    • US Elderly Population: Expected Growth Rates (%) Over the Years 2005-2025
    • Rising Incidence of Cancer: A Major Growth Driver
    • Estimated Number of New Cancer Cases in the US by Gender and Affected Site for 2021
    • Estimated Number of Cancer-Related Deaths in the US by Gender and Body Site for 2021
    • Estimated Number of New Cancer Cases in the US by State for 2021
    • Estimated Number of Cancer-Related Deaths in the US by State for 2021
    • Cardiovascular Imaging to Lead Volume Growth
    • Radiopharmaceuticals Usage Grows in PET Imaging
    • Radioisotope/Radiopharmaceuticals Supply Scenario
    • Passing of Medicare Diagnostic Radiopharmaceutical Payment Equity Act
    • Market Analytics
    • TABLE 41: USA Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 43: USA 14-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 46: USA 14-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 49: USA 14-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • CANADA
    • Market Overview
    • Efforts on to Address Mo-99 Supply Shortage
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 52: Canada 14-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 55: Canada 14-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 58: Canada 14-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • JAPAN
    • Radiopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • Market Overview
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 61: Japan 14-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 64: Japan 14-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 67: Japan 14-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • CHINA
    • Radiopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • Market Overview
    • TABLE 68: China Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 70: China 14-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 73: China 14-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 76: China 14-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • EUROPE
    • Market Facts & Figures
    • European Radiopharmaceuticals Market: Competitor Market Share Scenario (in %) for 2020 & 2027
    • SPECT Radioisotopes (Product Type) Market Share (in %) by Company in Europe: 2020 & 2027
    • PET Radioisotopes (Product Type) Market Share (in %) of Major Players in Europe: 2020 & 2027
    • Beta Emitters (Product Type) Competitor Market Share Analysis (in %) in Europe: 2020 & 2027
    • Alpha Emitters (Product Type) Market in Europe: Competitor Revenue Share Shift (in %) for 2020 & 2027
    • Radiopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • Market Overview
    • Market Analytics
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Radiopharmaceuticals by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Radiopharmaceuticals by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 79: Europe 14-Year Perspective for Radiopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2016, 2023 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 82: Europe 14-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 85: Europe 14-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 88: Europe 14-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • FRANCE
    • Radiopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 91: France 14-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 94: France 14-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 97: France 14-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • GERMANY
    • Radiopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 100: Germany 14-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 103: Germany 14-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 106: Germany 14-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 109: Italy 14-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 112: Italy 14-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 115: Italy 14-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • UNITED KINGDOM
    • Radiopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 118: UK 14-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 121: UK 14-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 124: UK 14-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • SPAIN
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 127: Spain 14-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 130: Spain 14-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 133: Spain 14-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • RUSSIA
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 136: Russia 14-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 139: Russia 14-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 142: Russia 14-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • REST OF EUROPE
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 145: Rest of Europe 14-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 148: Rest of Europe 14-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 151: Rest of Europe 14-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • ASIA-PACIFIC
    • Radiopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • Market Overview
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Radiopharmaceuticals by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Radiopharmaceuticals by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 154: Asia-Pacific 14-Year Perspective for Radiopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2016, 2023 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 157: Asia-Pacific 14-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 160: Asia-Pacific 14-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 163: Asia-Pacific 14-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • AUSTRALIA
    • Radiopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 166: Australia 14-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 169: Australia 14-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 172: Australia 14-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • INDIA
    • Radiopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • Market Overview
    • TABLE 173: India Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 175: India 14-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 178: India 14-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 181: India 14-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • SOUTH KOREA
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 184: South Korea 14-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 187: South Korea 14-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 190: South Korea 14-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 14-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 14-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 14-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • LATIN AMERICA
    • Radiopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Radiopharmaceuticals by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Radiopharmaceuticals by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 202: Latin America 14-Year Perspective for Radiopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2016, 2023 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 205: Latin America 14-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 208: Latin America 14-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 211: Latin America 14-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • ARGENTINA
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 214: Argentina 14-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 217: Argentina 14-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 220: Argentina 14-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • BRAZIL
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 223: Brazil 14-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 226: Brazil 14-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 229: Brazil 14-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • MEXICO
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 232: Mexico 14-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 235: Mexico 14-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 238: Mexico 14-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 241: Rest of Latin America 14-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 244: Rest of Latin America 14-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 247: Rest of Latin America 14-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • MIDDLE EAST
    • Radiopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Radiopharmaceuticals by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Radiopharmaceuticals by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 250: Middle East 14-Year Perspective for Radiopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2016, 2023 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 253: Middle East 14-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 256: Middle East 14-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 259: Middle East 14-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • IRAN
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 262: Iran 14-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 265: Iran 14-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 268: Iran 14-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • ISRAEL
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 271: Israel 14-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 274: Israel 14-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 277: Israel 14-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • SAUDI ARABIA
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 280: Saudi Arabia 14-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 283: Saudi Arabia 14-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 286: Saudi Arabia 14-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 289: UAE 14-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 292: UAE 14-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 295: UAE 14-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • REST OF MIDDLE EAST
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 298: Rest of Middle East 14-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 301: Rest of Middle East 14-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 304: Rest of Middle East 14-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2023 & 2030
  • AFRICA
    • Radiopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2021 and % CAGR
    • TABLE 307: Africa 14-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2023 & 2030
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!